NAC Logo

Health Professionals
Asthma Management HandbookAsthma Action PlansSpirometry ResourcesInformation PapersOther ResourcesProfessional Development
Asthma Management Handbook 2006
Home
AMH 2006 PDF - for print
Member Organisations
Sponsors
Contributors
Note to the Sixth Edition
Contents
Introduction
Levels of evidence
Asthma: the basic facts
Diagnosis in adults
Diagnosis in children
Principles of drug therapy
Drugs and devices
Acute asthma
Managing exacerbations
Complementary medicine
Diet and asthma
Asthma and allergy
Ongoing care
Smoking and asthma
COPD and asthma
Exercise-induced asthma
Occupational asthma
Pregnancy and asthma
Asthma in the elderly
Other comorbidities
Prevention
Appendices
References
Errata

Home
Print E-mail

Drugs and devices

Note on ICS-equivalents: Consistent with international guideline publications, stated inhaled corticosteroid doses are expressed in beclomethasone dipropionate- (BDP-HFA)-equivalents for simplicity and editorial economy, and do not indicate a recommendation of any particular agent within this drug class. To calculate equivalent doses of other formulations, see Table 1. ICS dose equivalents

There are three main groups of asthma medications:

  • Relievers
  • Preventers
  • Symptom controllers - usually prescribed in combination with an inhaled corticosteroid (ICS) preventer.

Combination medications consist of an ICS and a symptom controller in a single inhaler device.

 

Content Created (Thursday, 16 November 2006)

Last Updated ( Thursday, 31 May 2007 )
 
Next >
Advanced Search AMH 2006
Search NAC Website
AMH 2006 PDF - for print
Obtain the AMH 2006
Login





Lost Password?
No account yet? Register
Top 20 AMH 2006 areas